MIF and autosomal dominant polycystic kidney disease: The MIF inhibitor ISO-1 attenuates HIF-1α- and cAMP-dependent cyst enlargement and can also be used as a therapeutic target to delay cyst growth in ADPKD [27] (Table 2).